Expert Details
Pharmaceutical Quality Assurance, Quality Control, Supplier Selection and Supplier Quality
ID: 729549
California, USA
He has designed quality system for a US virtual pharmaceutical manufacturer to enable the firm introduce its products, manufactured in Asia, into the US marketplace. He has implemented SOPs, Quality and Supply Agreements and GMP Training programs for clients.He has conducted several audits of API and finished products manufacturers for clients. He has also helped clients select vendors. He has conducted audits in the United States, India, China, and Europe.He was a member of a client's Due Diligence team that evaluated acquisition targets. Provided QA/QC input to the team, including risk assessment.He has conducted a gap analysis of a client's Quality System, put together a Remediation Plan and guided the implementation of the plan.He is currently leading a team of experts that is conducting a feasibility study of building a Sterile Manufacturing plant in Nigeria.
Education
| Year | Degree | Subject | Institution |
|---|---|---|---|
| Year: 1988 | Degree: PhD | Subject: Industrial Pharmacy | Institution: St. John's University, New York |
| Year: 1984 | Degree: MS | Subject: Industrial Pharmacy | Institution: St. John's University, New York |
| Year: 1979 | Degree: BS | Subject: Chemistry | Institution: University of Ibadan, Nigeria |
Work History
| Years | Employer | Title | Department |
|---|---|---|---|
| Years: 2007 to 2011 | Employer: OnyexxPharma LLC | Title: CEO | Department: |
Responsibilities:He is an independent compliance consultant specializing in pharmaceutical, biopharmaceutical, and medical device GMP-compliance issues. He guides pharmaceutical and allied product manufacturers in the U.S. and Asia in the introduction of new products and technologies in the U.S., Africa, and other emerging economies. |
|||
| Years | Employer | Title | Department |
| Years: 2005 to 2007 | Employer: Spectrum Pharmaceuticals Inc. | Title: Vice President, Global Quality Operations | Department: QA/QC |
Responsibilities:He was responsible for quality assurance / quality control initiatives in support of global drug development, clinical supplies manufacturing, commercial drug manufacturing, pre-approval inspections for new product introductions, and due-diligence efforts for in-and out-licensing activities. He implemented systems that assured laboratory and study sites in the U.S. and Europe were in full compliance. |
|||
| Years | Employer | Title | Department |
| Years: 2003 to 2005 | Employer: Purdue Pharma LP | Title: Executive Director | Department: External Manufacturing & Supplier Quality |
Responsibilities:He spearheaded quality and risk-management activities pivotal for the successful launch of multimillion-dollar products sourced from third-party manufacturers and packagers. He implemented supplier auditing and qualification programs and quality and supply agreements. He provided quality directions for potential acquisition targets. |
|||
| Years | Employer | Title | Department |
| Years: 2001 to 2003 | Employer: Purdue Pharma LP | Title: Executive Director | Department: Manufacturing Quality |
Responsibilities:He led quality control and quality assurance activities for all plant operations for a $2,000,000,000.00, three-plant operation. He acted as company liaison during FDA Inspections and led the development of responses to inspection observations and implementation of corrective / preventive-action plans. |
|||
| Years | Employer | Title | Department |
| Years: 1997 to 2001 | Employer: Ortho-McNeil Pharmaceuticals (J&J) | Title: Site Director, QA/QC | Department: Quality |
Responsibilities:He managed a staff of over 90 responsible for manufacturing quality and compliance development and oversight for two plants representing over $2,000,000,000 in annual sales. Provided leadership in designing and implementing "Lean Lab" at the Raritan site. |
|||
| Years | Employer | Title | Department |
| Years: 1994 to 1997 | Employer: Hoffmann-La Roche Inc., New Jersey | Title: Group Leader, Analytics | Department: Quality Management |
Responsibilities:He led 40 scientists engaged in analytical R&D, troubleshooting of Operations' technical issues, stability testing and management, methods development and optimization and laboratory automation. |
|||
| Years | Employer | Title | Department |
| Years: 1991 to 1994 | Employer: Hoffmann-La Roche | Title: Associate Research Investigator | Department: Quality Management |
Responsibilities:Led a team of chemists that developed and validated analytical methods, developed and compiled the CMC section of NDAs. |
|||
Career Accomplishments
| Associations / Societies |
|---|
| AAPS (American Association for Pharmaceutical Scientists); ISPE; PDA |
Fields of Expertise
analytical data quality assurance, auditing, biotechnology quality assurance, continuous quality improvement, contract compliance, Current Good Manufacturing Practice, drug product approval, Food and Drug Administration, Food and Drug Administration compliance, Food and Drug Administration food packaging regulation, global regulatory procedure, inspection, laboratory quality assurance, manufacturing documentation system, manufacturing quality assurance, manufacturing quality control, medical device, medical device auditing, medical device inspection, medical device manufacturing quality control, pharmaceutical analysis, pharmaceutical drug, pharmaceutical industry, pharmaceutical liquid, pharmaceutical manufacturer, pharmaceutical manufacturing facility auditing, pharmaceutical quality assurance, pharmaceutical quality control, pre-approval inspection, product approval, product evaluation, quality, quality assurance, quality assurance management system, quality assurance project plan, quality auditing, quality control, quality documentation product, quality evaluation, quality improvement, quality management, quality standard, regulatory compliance auditing, supplier quality assurance, supplier quality improvement, vendor quality auditing, vendor selection, active pharmaceutical ingredient, internal audit, ISO 9000 auditing, ISO 9000 series quality system standard, operational auditing, ophthalmic pharmaceutical product, quality statistical method, quality-by-design, risk based inspection, drug regulation, QS-9000 quality system requirements, qualification testing, manufacturing process development, biotechnology